blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP3077026

EP3077026 - DOSE DIVIDER SYRINGE [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  12.02.2021
Database last updated on 09.07.2024
FormerThe patent has been granted
Status updated on  06.03.2020
FormerGrant of patent is intended
Status updated on  05.12.2019
FormerExamination is in progress
Status updated on  05.10.2018
Most recent event   Tooltip15.07.2022Lapse of the patent in a contracting state
New state(s): BE		published on 17.08.2022  [2022/33]
Applicant(s)For all designated states
Teleflex Medical Incorporated
3015 Carrington Mill Boulevard
Morrisville, North Carolina 27560 / US
[2020/15]
Former [2016/41]For all designated states
Teleflex Medical Incorporated
3015 Carrington Mill Boulevard
Morrisville, North Carolina 27560 / US
Inventor(s)01 / TRAN, Huy
11878 South Reeves Lane
Riverton, Utah 84065 / US
02 / CROLL, Perry
2063 East Glacier View Drive
Sandy, Utah 84092 / US
 [2016/41]
Representative(s)Atout PI Laplace
Immeuble Up On
25 Boulevard Romain Rolland
CS 40072
75685 Paris Cedex 14 / FR
[N/P]
Former [2020/15]Bell, Mark
Marks & Clerk France
Immeuble «Visium»
22, avenue Aristide Briand
94117 Arcueil Cedex / FR
Former [2016/41]Nguyen Van Yen, Christian
Marks & Clerk France
Conseils en Propriété Industrielle
Immeuble Visium
22, Avenue Aristide Briand
94117 Arcueil Cedex / FR
Application number, filing date14867769.305.12.2014
[2016/41]
WO2014US68868
Priority number, dateUS201361912715P06.12.2013         Original published format: US 201361912715 P
[2016/41]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2015085215
Date:11.06.2015
Language:EN
[2015/23]
Type: A1 Application with search report 
No.:EP3077026
Date:12.10.2016
Language:EN
The application published by WIPO in one of the EPO official languages on 11.06.2015 takes the place of the publication of the European patent application.
[2016/41]
Type: B1 Patent specification 
No.:EP3077026
Date:08.04.2020
Language:EN
[2020/15]
Search report(s)International search report - published on:US11.06.2015
(Supplementary) European search report - dispatched on:EP20.07.2017
ClassificationIPC:A61M5/315
[2016/41]
CPC:
A61M5/31591 (EP,US); A61M2205/6081 (EP,US); A61M5/31553 (EP,US);
A61M5/3156 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2016/41]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:DOSISTEILER-SPRITZE[2016/41]
English:DOSE DIVIDER SYRINGE[2016/41]
French:SERINGUE À SÉPARATEUR DE DOSE[2016/41]
Entry into regional phase04.07.2016National basic fee paid 
04.07.2016Search fee paid 
04.07.2016Designation fee(s) paid 
04.07.2016Examination fee paid 
Examination procedure04.07.2016Examination requested  [2016/41]
16.02.2018Amendment by applicant (claims and/or description)
04.10.2018Despatch of a communication from the examining division (Time limit: M06)
09.04.2019Reply to a communication from the examining division
06.12.2019Communication of intention to grant the patent
25.02.2020Fee for grant paid
25.02.2020Fee for publishing/printing paid
25.02.2020Receipt of the translation of the claim(s)
Opposition(s)12.01.2021No opposition filed within time limit [2021/11]
Fees paidRenewal fee
27.12.2016Renewal fee patent year 03
27.12.2017Renewal fee patent year 04
31.12.2018Renewal fee patent year 05
27.12.2019Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU05.12.2014
AL08.04.2020
AT08.04.2020
CY08.04.2020
CZ08.04.2020
DK08.04.2020
EE08.04.2020
ES08.04.2020
FI08.04.2020
HR08.04.2020
IT08.04.2020
LT08.04.2020
LV08.04.2020
MC08.04.2020
MK08.04.2020
MT08.04.2020
NL08.04.2020
PL08.04.2020
RO08.04.2020
RS08.04.2020
SE08.04.2020
SI08.04.2020
SK08.04.2020
SM08.04.2020
TR08.04.2020
BG08.07.2020
NO08.07.2020
GR09.07.2020
IS08.08.2020
PT17.08.2020
IE05.12.2020
LU05.12.2020
BE31.12.2020
CH31.12.2020
LI31.12.2020
[2022/33]
Former [2022/32]HU05.12.2014
AL08.04.2020
AT08.04.2020
CY08.04.2020
CZ08.04.2020
DK08.04.2020
EE08.04.2020
ES08.04.2020
FI08.04.2020
HR08.04.2020
IT08.04.2020
LT08.04.2020
LV08.04.2020
MC08.04.2020
MK08.04.2020
MT08.04.2020
NL08.04.2020
PL08.04.2020
RO08.04.2020
RS08.04.2020
SE08.04.2020
SI08.04.2020
SK08.04.2020
SM08.04.2020
TR08.04.2020
BG08.07.2020
NO08.07.2020
GR09.07.2020
IS08.08.2020
PT17.08.2020
IE05.12.2020
LU05.12.2020
CH31.12.2020
LI31.12.2020
Former [2022/27]HU05.12.2014
AL08.04.2020
AT08.04.2020
CY08.04.2020
CZ08.04.2020
DK08.04.2020
EE08.04.2020
ES08.04.2020
FI08.04.2020
HR08.04.2020
IT08.04.2020
LT08.04.2020
LV08.04.2020
MC08.04.2020
MT08.04.2020
NL08.04.2020
PL08.04.2020
RO08.04.2020
RS08.04.2020
SE08.04.2020
SI08.04.2020
SK08.04.2020
SM08.04.2020
TR08.04.2020
BG08.07.2020
NO08.07.2020
GR09.07.2020
IS08.08.2020
PT17.08.2020
IE05.12.2020
LU05.12.2020
CH31.12.2020
LI31.12.2020
Former [2021/52]AL08.04.2020
AT08.04.2020
CZ08.04.2020
DK08.04.2020
EE08.04.2020
ES08.04.2020
FI08.04.2020
HR08.04.2020
IT08.04.2020
LT08.04.2020
LV08.04.2020
MC08.04.2020
NL08.04.2020
PL08.04.2020
RO08.04.2020
RS08.04.2020
SE08.04.2020
SI08.04.2020
SK08.04.2020
SM08.04.2020
BG08.07.2020
NO08.07.2020
GR09.07.2020
IS08.08.2020
PT17.08.2020
IE05.12.2020
LU05.12.2020
CH31.12.2020
LI31.12.2020
Former [2021/47]AL08.04.2020
AT08.04.2020
CZ08.04.2020
DK08.04.2020
EE08.04.2020
ES08.04.2020
FI08.04.2020
HR08.04.2020
IT08.04.2020
LT08.04.2020
LV08.04.2020
MC08.04.2020
NL08.04.2020
PL08.04.2020
RO08.04.2020
RS08.04.2020
SE08.04.2020
SI08.04.2020
SK08.04.2020
SM08.04.2020
BG08.07.2020
NO08.07.2020
GR09.07.2020
IS08.08.2020
PT17.08.2020
IE05.12.2020
LU05.12.2020
Former [2021/46]AL08.04.2020
AT08.04.2020
CZ08.04.2020
DK08.04.2020
EE08.04.2020
ES08.04.2020
FI08.04.2020
HR08.04.2020
IT08.04.2020
LT08.04.2020
LV08.04.2020
MC08.04.2020
NL08.04.2020
PL08.04.2020
RO08.04.2020
RS08.04.2020
SE08.04.2020
SI08.04.2020
SK08.04.2020
SM08.04.2020
BG08.07.2020
NO08.07.2020
GR09.07.2020
IS08.08.2020
PT17.08.2020
IE05.12.2020
Former [2021/40]AL08.04.2020
AT08.04.2020
CZ08.04.2020
DK08.04.2020
EE08.04.2020
ES08.04.2020
FI08.04.2020
HR08.04.2020
IT08.04.2020
LT08.04.2020
LV08.04.2020
MC08.04.2020
NL08.04.2020
PL08.04.2020
RO08.04.2020
RS08.04.2020
SE08.04.2020
SI08.04.2020
SK08.04.2020
SM08.04.2020
BG08.07.2020
NO08.07.2020
GR09.07.2020
IS08.08.2020
PT17.08.2020
Former [2021/24]AL08.04.2020
AT08.04.2020
CZ08.04.2020
DK08.04.2020
EE08.04.2020
ES08.04.2020
FI08.04.2020
HR08.04.2020
IT08.04.2020
LT08.04.2020
LV08.04.2020
NL08.04.2020
PL08.04.2020
RO08.04.2020
RS08.04.2020
SE08.04.2020
SI08.04.2020
SK08.04.2020
SM08.04.2020
BG08.07.2020
NO08.07.2020
GR09.07.2020
IS08.08.2020
PT17.08.2020
Former [2021/10]AL08.04.2020
AT08.04.2020
CZ08.04.2020
DK08.04.2020
EE08.04.2020
ES08.04.2020
FI08.04.2020
HR08.04.2020
IT08.04.2020
LT08.04.2020
LV08.04.2020
NL08.04.2020
PL08.04.2020
RO08.04.2020
RS08.04.2020
SE08.04.2020
SK08.04.2020
SM08.04.2020
BG08.07.2020
NO08.07.2020
GR09.07.2020
IS08.08.2020
PT17.08.2020
Former [2021/09]AL08.04.2020
AT08.04.2020
CZ08.04.2020
DK08.04.2020
EE08.04.2020
ES08.04.2020
FI08.04.2020
HR08.04.2020
IT08.04.2020
LT08.04.2020
LV08.04.2020
NL08.04.2020
RO08.04.2020
RS08.04.2020
SE08.04.2020
SM08.04.2020
BG08.07.2020
NO08.07.2020
GR09.07.2020
IS08.08.2020
PT17.08.2020
Former [2021/08]AL08.04.2020
DK08.04.2020
ES08.04.2020
FI08.04.2020
HR08.04.2020
LT08.04.2020
LV08.04.2020
NL08.04.2020
RO08.04.2020
RS08.04.2020
SE08.04.2020
SM08.04.2020
BG08.07.2020
NO08.07.2020
GR09.07.2020
IS08.08.2020
PT17.08.2020
Former [2021/04]AL08.04.2020
FI08.04.2020
HR08.04.2020
LT08.04.2020
LV08.04.2020
NL08.04.2020
RS08.04.2020
SE08.04.2020
BG08.07.2020
NO08.07.2020
GR09.07.2020
IS08.08.2020
PT17.08.2020
Former [2021/01]FI08.04.2020
HR08.04.2020
LT08.04.2020
LV08.04.2020
NL08.04.2020
RS08.04.2020
SE08.04.2020
BG08.07.2020
NO08.07.2020
GR09.07.2020
IS08.08.2020
PT17.08.2020
Former [2020/51]FI08.04.2020
HR08.04.2020
LT08.04.2020
LV08.04.2020
NL08.04.2020
RS08.04.2020
SE08.04.2020
NO08.07.2020
GR09.07.2020
IS08.08.2020
PT17.08.2020
Former [2020/50]FI08.04.2020
HR08.04.2020
LT08.04.2020
LV08.04.2020
NL08.04.2020
SE08.04.2020
NO08.07.2020
GR09.07.2020
IS08.08.2020
PT17.08.2020
Former [2020/48]FI08.04.2020
LT08.04.2020
NL08.04.2020
SE08.04.2020
NO08.07.2020
IS08.08.2020
PT17.08.2020
Former [2020/47]LT08.04.2020
NO08.07.2020
IS08.08.2020
Former [2020/46]IS08.08.2020
Documents cited:Search[XI]WO03004080  (AKZO NOBEL NV [NL], et al) [X] 1-4,7,8,12,14,16 * figures 1, 2a-d * * page 4, line 22 - page 5, line 2 * [I] 5,6,9-11,13,15;
 [X]WO2011073176  (NOVARTIS AG [CH], et al) [X] 1-3 * figures 1, 2 ** page 9, lines 11-22 *
International search[A]US5601077  (IMBERT CLAUDE [FR]);
 [A]US5833669  (WYRICK RONALD E [US]);
 [A]US5951526  (KORISCH MARINA [US], et al);
 [A]US5954695  (SIMS NATHANIEL M [US], et al);
 [A]US7041085  (PEREZ ANTHONY R [US], et al);
 [A]US7296566  (ALCHAS PAUL G [US]);
 [A]US8535277  (ODEN MARIA [US], et al);
 [A]US2013289493  (BANEY BRUNO [FR], et al)
by applicantUS5009645
 US5318544
 US5601077
 US5951526
 US2003004467
 WO03004080
 US2005137532
 WO2011073176
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.